Dr Adam Irving has recently published a paper in PloS One titled "Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry". This study used MRDR data to develop and validate the EpiMAP Myeloma model, a discrete-event simulation model, to provide long-term prognostic information to patients, clinicians and policymakers.
Thank you to all patients, MRDR site staff and investigators for your contribution to this, and congratulations to Dr. Adam Irving on this publication!